October 5, 2021 CURE ID: Capturing Clinician’s Experiences Repurposing Drugs to Inform Future Studies in the Era of COVID-19
September 24, 2021 Critical Path for Parkinson’s Consortium 3DT Initiative: Recommendations for involving people with Parkinson’s in clinical studies using digital health tools Recommendations for involving people with Parkinson’s in clinical studies using digital health tools
June 27, 2021-July 1, 2021 The Rare Disease Clinical Outcome Assessment Consortium: Collaboration Aimed at Accelerating Rare Disease Drug Development Presented at the DIA Virtual Global Annual Meeting, held June 27 – July 1, 2021.
May 7, 2021 COVID-19 Mitigation Strategies in Pediatric Rare Disease Clinical Trials Virtual Workshop The Patient-Reported Outcome Consortium’s Rare Disease Subcommittee is pleased to invite you to view the complimentary virtual w
April 14, 2021-April 15, 2021 Identifying COAs for Use in Rare Disease Treatment Trials Presented at the PRO Consortium 2021 Workshop, held virtually April 14-15, 2021:
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy Abstract WMS 2020
April 7, 2021 Development of a regulatory-ready clinical trial simulation tool for Duchenne muscular dystrophy poster WMS 2020
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Abstract WMS 2019
April 7, 2021 Development of Clinical Trial Simulation Tool for Duchenne Muscular Dystrophy Through the Duchenne Regulatory Science Poster WMS 2019
